MMSE and MoCA feasibility in Parkinson’s disease and dementia with Lewy bodies: A multicenter 1-year follow-up study
Objective: The aims of this study were to investigate which scale is best suited to assess cognition and more sensitive to cognitive decline over time…Validation of the XDP-MDSP rating scale for the evaluation of patients with X-linked dystonia-parkinsonism (XDP)
Objective: To validate the proposed XDP-MDSP (X-linked dystonia-parkinsonism – The Movement Disorder Society of the Philippines) rating scale in patients clinically diagnosed to have XDP.…Usefulness of total neuropathy score revised as a screening tool of peripheral neuropathy in patients with Parkinson’s disease
Objective: To evaluate (1) prevalence of peripheral neuropathy and (2) usefulness of known neuropathy scores in patients with Parkinson's disease (PD). Background: Peripheral neuropathy has…Screening of posterior cortical dysfunction in early Parkinson’s disease with mild cognitive impairment as an approach to select patients at higher risk for developing dementia
Objective: Based on the importance of progressive dysfunction of posterior cortical regions in cognitive deterioration in PD, we explored whether posterior cortical dysfunction in early…Comorbid conditions associated with Parkinson´s disease: A longitudinal study
Objective: (1)To study what comorbid conditions were present at baseline and 3 years later in a cohort of Spanish PD patients and (2) to analyze…Scores and dimensions to assess cognitive impairment in Parkinson’s disease
Objective: To provide inside into the nature of cognitive deterioration in Parkinson's disease dementia (PDD) and to define a score discriminating PDD patients from non-demented…Measuring interdependence of the health status of people with Parkinson’s disease and their spouses
Objective: To demonstrate an innovative visualization method for measuring the interdependence of the health status of people with Parkinson's disease (PD) and their spouses over…Staging of cognitive impairment: Validation of a novel cognitive score with [18F]FDG-PET
Objective: To provide insight into the nature of cognitive deterioration and Parkinson's disease dementia (PDD) and to validate a novel cognitive score (also submitted for…Clinically ‘slight’ bradykinesia in Parkinson’s disease is accurately detected using evolutionary computation analysis of finger tapping
Objective: To assess whether MDS-UPDRS grade one Parkinson's disease (PD) bradykinesia can be accurately detected by a novel non-invasive device that analyses a standard finger…Cognition and amyloid biomarker status in non-demented patients with Parkinson’s disease patients (PD) with or without subjective cognitive decline (SCD)
Objective: To compare the cognitive and Amyloid-beta 1-42 profile of non-demented Parkinson's disease patients (PD) reporting subjective cognitive decline (SCD) with or without concerns regarding…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.